As a result of the inspection, the laboratory received a positive Sanitary and Epidemiological Conclusion and a license from Rospotrebnadzor for working with microorganisms of III-IV pathogenicity groups.
As a result of the inspection, the laboratory received a positive Sanitary and Epidemiological Conclusion and a license from Rospotrebnadzor for working with microorganisms of III-IV pathogenicity groups.
The PharmEco Group of Companies will build a pharmaceutical manufacturing facility for oncology treatments in…
The Russian government has approved updated regulations governing the release of medicines into civil circulation.…
The Russian government has amended its decree on measures for granting national treatment in the…
From January to April 2025, medicine sales in Russia reached 1.03 trillion rubles. Compared to…
Pfizer CEO Albert Bourla has called on European countries to increase their spending on medicines.…